Crosslinkable liquid compositions used in methods for treating or preventing eye disorders
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- UNIVERSITEIT ANTWERPEN
- Filing Date
- 2024-04-26
- Publication Date
- 2026-06-19
AI Technical Summary
Current methods for correcting refractive errors and protecting against UV and HEV light exposure have limitations such as tissue removal risks, reversibility issues, and irreversible solutions like intraocular lenses, along with complications from laser surgery and blue light filters.
A crosslinkable liquid composition comprising gelatin functionalized with tyrosine derivative or phenol groups and a visible light and/or UV light photoinitiator system is applied to the cornea, crosslinked in situ, forming corneal inlays or onlays that provide UV and HEV light blocking properties, allowing for rapid treatment and correction of corneal curvature without tissue removal.
The method offers a long-lasting, reversible solution for treating refractive errors and protecting against UV and HEV light, reducing postoperative complications and providing a wider treatment range than laser surgery, with rapid crosslinking dynamics and immediate protection from harmful light.
Smart Images
Figure 2026519953000001 
Figure 2026519953000002 
Figure 2026519953000003